Elsevier, The Lancet Regional Health - Western Pacific, Volume 16, November 2021
Background: To discuss a range of strategic options for China to improve the accessibility of direct antiviral agents (DAAs) as the treatment for hepatitis C.
Elsevier, The Lancet Planetary Health, Volume 5, November 2021
An Article in support of SDGs 12 and 13, assessing the potential benefits of moving to more sustainable diets for greenhouse gas emissions, land use, mortality, and cancer rates.
Elsevier, Public Health in Practice, Volume 2, November 2021
Looks at the mental health of the Black community in the USA in response to police brutality. Ties to reduced inequalities, peace and justice, good health and wellbeing for all.
Understanding the cause and functional consequences of MINCR deregulation gives important insights on potential pathogenetic mechanisms both in cancer and in neurodegeneration.
Elsevier, The Journal of Climate Change and Health, Volume 5, 2022, 100092
As both COVID-19 and climate change crises converged and even contributed to each other, a much older crisis reemerged: structural racism and the policy stagnation that refuses to address it.
Barth syndrome (BTHS) is a rare X-linked multisystem mitochondrial disease. It is caused by variants of the TAFAZZIN gene leading to abnormal cardiolipin. Normal cardiolipin is crucial for proper mitochondrial structure and function. This article reviews the little-discussed, but significant neuro/psychological aspects of BTHS and discusses potential pathogenic mechanisms and avenues for further research.
Elsevier, The Lancet Neurology, Volume 20, November 2021
An article on treatment for Alzheimer's disease, in the context of SDG 3, focusing specifically on whether an angiotensin II receptor antagonist can reduce brain volume loss.